Mesenchymal cell fate and phenotypes in the pathogenesis of emphysema

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 3, 2009, Pages 201-210

  Horowitz, Jeffrey C ^a   Martinez, Fernando J ^a   Thannickal, Victor J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Chronic Obstructive Pulmonary Disease: A Global Health Crisis; Extracellular matrix; Fibroblast; Myofibroblast; Repair; TGF 1

Indexed keywords

CIGARETTE SMOKE; PROTEINASE; PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

AIRWAY OBSTRUCTION; CELL FATE; CELL FUNCTION; CELL REGENERATION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONNECTIVE TISSUE; DYSPNEA; EMPHYSEMA; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; HEREDITY; HOMEOSTASIS; HUMAN; HYPERINFLATION; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG COMPLIANCE; LUNG DEVELOPMENT; LUNG INJURY; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; WOUND HEALING;

EPITHELIAL CELLS; FIBROBLASTS; HUMANS; MESODERM; PHENOTYPE; PULMONARY EMPHYSEMA; SMOKING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70350437995     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550902905953     Document Type: Review

References (118)

1. Friedlander AL, Lynch D, Dyar LA, Bowler RP. Phenotypes of chronic obstructive pulmonary disease. COPD 2007; 4:355-384.
2. Celli BR, Roger S. Mitchell Lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. Proc Am Thorac Soc 2006; 3:461-465.
3. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS,Mannino DM. Global burden of COPD systematic review and metaanalysis. Eur Respir J 2006; 28:523-532.
4. Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 2006; 3:503-510.
5. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. J Clin Invest 2008;118:394-402.
6. Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007; 370:765-773.
7. Jemal A,Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294:1255-1259.
8. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Nhlbi/Who Global Initiative for Chronic Obstructive Lung Disease (Gold) Workshop Summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
9. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27:188-207. (Pubitemid 43092683)
10. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87:1047-1082.
11. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K. Not 15 but 50% of smokers develop COPD?-Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97:115-122.
12. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364:709-721.
13. Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2689-2697.
14. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326-1334.
15. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073.
16. Churg A, Cosio M, Wright JL. Mechanisms of cigarette smokeinduced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 2008; 294:L612-631.
17. Togo S, Holz O, Liu X, Sugiura H, Kamio K,Wang X, Kawasaki S, Ahn Y, Fredriksson K, Skold CM, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008; 178:248-260.
18. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170:1807-1816.
19. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341:738-746.
20. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006; 116:753-759.
21. Adair-Kirk TL, Senior RM. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 2008; 40:1101-1110.
22. Thannickal VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006; 3:350-356.
23. Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, Pekna M, Hellstrom M, Gebre-Medhin S, Schalling M, et al. Pdgf-a signaling is a critical event in lung alveolarmyofibroblast development and alveogenesis. Cell 1996; 85:863-873.
24. Hogan BL, Yingling JM. Epithelial/mesenchymal interactions and branching morphogenesis of the lung. Curr Opin Genet Dev 1998; 8:481-486.
25. Bruce MC, Honaker CE, Cross RJ. Lung fibroblasts undergo apoptosis following alveolarization. Am J Respir Cell Mol Biol 1999; 20:228-236.
26. Horowitz JC, Thannickal VJ. Epithelial-mesenchymal interactions in pulmonary fibrosis. Semin Respir Crit Care Med 2006; 27:600-612.
27. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005; 13:7-12.
28. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3:349-363.
29. Thannickal VJ, Aldweib KD, Rajan T, Fanburg BL. Upregulated expression of fibroblast growth factor (fgf) receptors by transforming growth factor-beta-1 (Tgf-Beta1) mediates enhanced mitogenic responses to fgfs in cultured human lung fibroblasts. Biochem Biophys Res Commun 1998; 251:437-441.
30. Thannickal VJ, Fanburg BL. Activation of an H2O2-generating Nadh oxidase in human lung fibroblasts by transforming growth factor beta-1. J Biol Chem 1995; 270:30334-30338.
31. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, Thomas PE. Myofibroblast differentiation by transforming growth factor-beta-1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 2003; 278:12384-12389.
32. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146:56-66.
33. Horowitz JC, Thannickal VJ. Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy. Treat Respir Med 2006; 5:325-342.
34. Gauldie J, KolbM, Ask K, Martin G, Bonniaud P,Warburton D. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc 2006; 3:696-702.
35. Bradley KH, Kawanami O, Ferrans VJ, Crystal RG. The fibroblast of human lung alveolar structures: A differentiated cell with a major role in lung structure and function. Methods Cell Biol 1980; 21A:37-64.
36. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 126:332-337.
37. Sirianni FE, Milaninezhad A, Chu FS, Walker DC. Alteration of fibroblast architecture and loss of basal lamina apertures in human emphysematous lung. Am J Respir Crit Care Med 2006; 173:632-638.
38. Evans MJ, Van Winkle LS, Fanucchi MV, Plopper CG. The attenuated fibroblast sheath of the respiratory tract epithelialmesenchymal trophic unit. Am J Respir Cell Mol Biol 1999; 21:655-657.
39. Sirianni FE, Chu FS, Walker DC. Human alveolar wall fibroblasts directly link epithelial type 2 cells to capillary endothelium. Am J Respir Crit Care Med 2003; 168:1532-1537.
40. Kuhn C, 3rd, Boldt J, King TE, Jr., Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989; 140:1693-1703.
41. Shi Y, Massague J. Mechanisms of Tgf-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700.
42. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor Beta-1-an intimate relationship. Eur J Cell Biol 2008; 87(8-9):601-615.
43. Massague J, Wotton D. Transcriptional control by the Tgf- Beta/Smad signaling system. Embo J 2000; 19:1745-1754.
44. Derynck R, Zhang YE. Smad-dependent and Smadindependent pathways in Tgf-beta family signalling. Nature 2003; 425:577-584.
45. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342:1350-1358.
46. Letterio JJ, Roberts AB. Regulation of immune responses by Tgf-Beta. Annu Rev Immunol 1998; 16:137-161.
47. Willis BC, Borok Z. Tgf-beta-induced Emt: Mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293:L525-534.
48. Celedon JC, Lange C, Raby BA, Litonjua AA, Palmer LJ, DeMeo DL, Reilly JJ, Kwiatkowski DJ, Chapman HA, Laird N, et al. The transforming growth factor-beta1 (Tgfb1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum Mol Genet 2004;13:1649-1656.
49. Hersh CP, Demeo DL, Lazarus R, Celedon JC, Raby BA, Benditt JO, Criner G, Make B, Martinez FJ, Scanlon PD, et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:977-984.
50. Wu L, Chau J, Young RP, Pokorny V, Mills GD, Hopkins R, McLean L, Black PN. Transforming growth factor-beta-1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59:126-129.
51. Ogawa E, Ruan J, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Transforming growth factor-beta-1 polymorphisms, airway responsiveness and lung function decline in smokers. Respir Med 2007; 101:938-943.
52. DeMeo DL, Hersh CP, Hoffman EA, Litonjua AA, Lazarus R, Sparrow D, Benditt JO, Criner G, Make B, Martinez FJ, et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 2007; 176:42-48.
53. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-beta 1 Hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 2000; 97:3479-3484.
54. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D. Loss of integrin alpha(V)beta6-mediated Tgf-beta activation causes Mmp12- dependent emphysema. Nature 2003; 422:169-173.
55. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277:2002-2004.
56. Chen H, Sun J, Buckley S, Chen C, Warburton D, Wang XF, Shi W. Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema. Am J Physiol Lung Cell Mol Physiol 2005; 288:L683-691.
57. Bonniaud P, KolbM, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J. Smad3 null mice develop airspace enlargement and are resistant to Tgf-Betamediated pulmonary fibrosis. J Immunol 2004; 173:2099-2108.
58. Sterner-Kock A, Thorey IS, Koli K, Wempe F, Otte J, Bangsow T, Kuhlmeier K, Kirchner T, Jin S, Keski-Oja J, et al. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (Ltbp-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 2002; 16:2264-2273.
59. Horowitz JC, Rogers DS, Simon RH, Sisson TH, Thannickal VJ. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am J Respir Cell Mol Biol 2008; 38:78-87.
60. Chapman HA. Disorders of lung matrix remodeling. J Clin Invest 2004; 113:148-157.
61. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132:417-433.
62. Stone PJ, Morris SM, Thomas KM, Schuhwerk K, Mitchelson A. Repair of elastase-digested elastic fibers in acellular matrices by replating with neonatal rat-lung lipid interstitial fibroblasts or other elastogenic cell types. Am J Respir Cell Mol Biol 1997; 17:289-301.
63. Kuang PP, Zhang XH, Rich CB, Foster JA, Subramanian M, Goldstein RH. Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2007; 292:L944-952.
64. McGowan SE, McNamer R. Transforming growth factor-beta increases elastin production by neonatal rat lung fibroblasts. Am J Respir Cell Mol Biol 1990; 3:369-376.
65. Foster JA, Rich CB, Miller MF. Pulmonary fibroblasts: an in vitro model of emphysema. regulation of elastin gene expression. J Biol Chem 1990; 265:15544-15549.
66. DiCamillo SJ, Carreras I, Panchenko MV, Stone PJ, Nugent MA, Foster JA, Panchenko MP. Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin Mrna in lung fibroblasts. J Biol Chem 2002; 277:18938-18946.
67. DiCamillo SJ, Yang S, Panchenko MV, Toselli PA, Naggar EF, Rich CB, Stone PJ, Nugent MA, Panchenko MP. Neutrophil elastase-initiated EGFR/MEK/ERK signaling counteracts stabilizing effect of autocrine Tgf-Beta on Tropoelastin Mrna in Lung Fibroblasts. Am J Physiol Lung Cell Mol Physiol 2006; 291:L232-243.
68. Yang S, Nugent MA, Panchenko MP. Egf antagonizes Tgf-{Beta} induced tropoelastin expression in lung fibroblasts via stabilization of Smad corepressor Tgif. Am J Physiol Lung Cell Mol Physiol 2008 Jul; 295(1):L143-L151.
69. Churg A, Wang R, Wang X, Onnervik PO, Thim K, Wright JL. Effect of an Mmp-9/Mmp-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 2007; 62:706-713.
70. Foronjy R, Nkyimbeng T, Wallace A, Thankachen J, Okada Y, Lemaitre V, D'Armiento J. Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1149-1157.
71. Minematsu N, Nakamura H, Tateno H, Nakajima T, Yamaguchi K. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 2001; 289:116-119.
72. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26:602-609.
73. Seagrave J, Barr EB, March TH, Nikula KJ. Effects of cigarette smoke exposure and cessation on inflammatory cells and matrix metalloproteinase activity in mice. Exp Lung Res 2004; 30:1-15.
74. Selman M, Cisneros-Lira J, Gaxiola M, Ramirez R, Kudlacz EM, Mitchell PG, Pardo A. Matrix metalloproteinases inhibition attenuates tobacco smoke-induced emphysema in guinea pigs. Chest 2003; 123:1633-1641.
75. Demedts IK, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos GF, Pauwels RA, Brusselle GG. Elevated Mmp-12 protein levels in induced sputum from patients with COPD. Thorax 2006; 61:196-201.
76. Molet S, Belleguic C, Lena H, Germain N, Bertrand CP, Shapiro SD, Planquois JM, Delaval P, Lagente V. Increase in macrophage elastase (Mmp-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005; 54:31-36.
77. Imai K, Dalal SS, Chen ES, Downey R, Schulman LL, Ginsburg M, D'Armiento J. Human collagenase (Matrix Metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 2001; 163:786-791.
78. Fredriksson K, Liu XD, Lundahl J, Klominek J, Rennard SI, Skold CM. Red blood cells increase secretion of matrix metalloproteinases from human lung fibroblasts in vitro. Am J Physiol Lung Cell Mol Physiol 2006; 290:L326-333.
79. Zhu YK, Liu XD, Skold CM, Umino T, Wang HJ, Spurzem JR, Kohyama T, Ertl RF, Rennard SI. Synergistic neutrophil elastase-cytokine interaction degrades collagen in threedimensional culture. Am J Physiol Lung Cell Mol Physiol 2001; 281:L868-878.
80. Ning W, Dong Y, Sun J, Li C, Matthay MA, Feghali- Bostwick CA, Choi AM. Cigarette smoke stimulates matrix metalloproteinase-2 activity Via Egr-1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2007; 36:480-490.
81. Kim H, Liu X, Kohyama T, Kobayashi T, Conner H, Abe S, Fang Q, Wen FQ, Rennard SI. Cigarette smoke stimulates Mmp-1 production by human lung fibroblasts through the Erk1/2 pathway. COPD 2004; 1:13-23.
82. Skold CM, Liu X, Umino T, Zhu Y, Ohkuni Y, Romberger DJ, Spurzem JR, Heires AJ, Rennard SI. Human neutrophil elastase augments fibroblast-mediated contraction of released collagen gels. Am J Respir Crit Care Med 1999; 159:1138-1146.
83. Zhu Y, Skold CM, Liu X,Wang H, Kohyama T,Wen FQ, Ertl RF, Rennard SI. Fibroblasts and monocyte macrophages contract and degrade three-dimensional collagen gels in extended coculture. Respir Res 2001; 2:295-299.
84. Kohyama T, Liu X, Wen FQ, Zhu YK, Wang H, Kim HJ, Takizawa H, Cieslinski LB, Barnette MS, Rennard SI. Pde4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels. Am J Respir Cell Mol Biol 2002; 26:694-701.
85. MikkoM, Fredriksson K,WahlstromJ, Eriksson P,Grunewald J, Skold CM. Human T cells stimulate fibroblast-mediated degradation of extracellular matrix in vitro. Clin Exp Immunol 2008; 151:317-325.
86. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, Thannickal VJ. Combinatorial Activation of Fak and Akt by Transforming Growth Factor-Beta1 Confers an Anoikis-Resistant Phenotype to Myofibroblasts. Cell Signal 2007; 19:761-771.
87. Zhu YK, Umino T, Liu XD, Wang HJ, Romberger DJ, Spurzem JR, Rennard SI. Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival. In Vitro Cell Dev Biol Anim 2001; 37:10-16.
88. Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, Chambers RC. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical map kinase signalling pathways. J Cell Physiol 2001; 186:73-81.
89. Numanami H, Koyama S, Nelson DK, Hoyt JC, Freels JL, Habib MP, Amano J, Haniuda M, Sato E, Robbins RA. Serine protease inhibitors modulate smoke-induced chemokine release from human lung fibroblasts. Am J Respir Cell Mol Biol 2003; 29:613-619. (Pubitemid 37357713)
90. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006; 169:1155-1166.
91. Petrache I, Fijalkowska I, Zhen L,Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, et al. A novel antiapoptotic role for Alpha-1-antitrypsin in the prevention of pulmonary emphysema. AmJ Respir Crit CareMed 2006; 173:1222-1228.
92. Nakamura Y, Romberger DJ, Tate L, Ertl RF, Kawamoto M, Adachi Y, Mio T, Sisson JH, Spurzem JR, Rennard SI. Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med 1995; 151:1497-1503.
93. Wang H, Liu X, Umino T, Kohyama T, Zhu YK, Wen FQ, Spurzem JR, Romberger DJ, Kim HJ, Rennard SI. Effect of cigarette smoke on fibroblast-mediated gel contraction is dependent on cell density. Am J Physiol Lung Cell Mol Physiol 2003; 284:L205-213.
94. Carnevali S, Nakamura Y, Mio T, Liu X, Takigawa K, Romberger DJ, Spurzem JR, Rennard SI. Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am J Physiol 1998; 274:L591-598.
95. Kim HJ, Liu X, Wang H, Kohyama T, Kobayashi T, Wen FQ, Romberger DJ, Abe S,MacNeeW, Rahman I, et al. Glutathione prevents inhibition of fibroblast-mediated collagen gel contraction by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 2002; 283:L409-417.
96. Gao S, Chen K, Zhao Y, Rich CB, Chen L, Li SJ, Toselli P, Stone P, Li W. Transcriptional and posttranscriptional inhibition of lysyl oxidase expression by cigarette smoke condensate in cultured rat fetal lung fibroblasts. Toxicol Sci 2005; 87:197-203. (Pubitemid 41222672)
97. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006; 7:53.
98. Kim HP,Wang X, Chen ZH, Lee SJ, Huang MH,Wang Y, Ryter SW, Choi AM. Autophagic proteins regulate cigarette smokeinduced apoptosis: protective role of heme Oxygenase-1. Autophagy 2008; 4:887-895.
99. RyterSW, Chen ZH, Kim HP, Choi AM. Autophagy in chronic obstructive pulmonary disease: homeostatic or pathogenic mechanism? Autophagy 2009; 5(2):235-237.
100. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003; 111:81-90.
101. Ishii T, Matsuse T, Igarashi H, Masuda M, Teramoto S, Ouchi Y. Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase P1. Am J Physiol Lung Cell Mol Physiol 2001; 280:L1189-1195.
102. Carnevali S, Petruzzelli S, Longoni B, Vanacore R, Barale R, Cipollini M, Scatena F, Paggiaro P, Celi A, Giuntini C. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2003; 284:L955-963.
103. Baglole CJ, Bushinsky SM, Garcia TM, Kode A, Rahman I, Sime PJ, Phipps RP. Differential induction of apoptosis by cigarette smoke extract in primary human lung fibroblast strains: implications for emphysema. Am J Physiol Lung Cell Mol Physiol 2006; 291:L19-29.
104. Holz O, Zuhlke I, Jaksztat E, Muller KC,Welker L, Nakashima M, Diemel KD, Branscheid D, Magnussen H, Jorres RA. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004; 24:575-579.
105. Nobukuni S, Watanabe K, Inoue J, Wen FQ, Tamaru N, YoshidaM. Cigarette smoke inhibits the growth of lung fibroblasts from patients with pulmonary emphysema. Respirology 2002; 7:217-223.
106. Noordhoek JA, Postma DS, Chong LL, Vos JT, Kauffman HF, Timens W, van Straaten JF. Different proliferative capacity of lung fibroblasts obtained from control subjects and patients with emphysema. Exp Lung Res 2003; 29:291-302.
107. Plantier L, Marchand-Adam S, Antico VG, Boyer L, De Coster C, Marchal J, Bachoual R,Mailleux A, Boczkowski J, Crestani B. keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 2007; 293:L1230-1239.
108. Plantier L, Marchand-Adam S, Marchal-Somme J, Leseche G, Fournier M, Dehoux M, Aubier M, Crestani B. Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol 2005; 288:L641-647.
109. Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters- Golden M. Prostaglandin E(2) Inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E Prostanoid 2 receptor and camp signaling. Am J Physiol Lung Cell Mol Physiol 2007; 292:L405-413.
110. Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid Receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol 2003; 29:537-544.
111. Noordhoek JA, Postma DS, Chong LL, Menkema L, Kauffman HF, Timens W, van Straaten JF, van der Geld YM. Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema. COPD 2005; 2:17-25.
112. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006; 174:886-893.
113. Nyunoya T, Monick MM, KlingelhutzA, Yarovinsky TO,Cagley JR, Hunninghake GW. Cigarette smoke induces cellular senescence. Am J Respir Cell Mol Biol 2006; 35:681-688.
114. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390:45-51.
115. Sato T, Seyama K, Sato Y, Mori H, Souma S, Akiyoshi T, Kodama Y, Mori T, Goto S, Takahashi K, et al. Senescencemarker Protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 2006; 174:530-537.
116. Araya J, Cambier S, Markovics JA, Wolters P, Jablons D, Hill A, Finkbeiner W, Jones K, Broaddus VC, Sheppard D, et al. Squamous metaplasia amplifies pathologic epithelialmesenchymal interactions in COPD patients. J Clin Invest 2007; 117:3551-3562.
117. Wang CH, Huang CD, Lin HC, Lee KY, Lin SM, Liu CY, Huang KH, Ko YS, Chung KF, Kuo HP. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 2008; 178:583-591.
118. Ramirez AM, Shen Z, Ritzenthaler JD, Roman J. Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways. Am J Transplant 2006; 6:2080-2088.